74,046 results match your criteria percutaneous coronary


Fifth Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report.

Ann Thorac Surg 2021 Oct 11. Epub 2021 Oct 11.

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Background: The Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) provides detailed information on pediatric patients supported with ventricular assist devices (VADs).

Methods: From September 19, 2012 to December 31, 2020 there were 1,229 devices in 1,011 patients reported to the registry from 47 North American Hospitals in patients under 19 years of age.

Results: Cardiomyopathy was the most common underlying etiology (58%), followed by congenital heart disease (CHD) (25%) and myocarditis (10%). Read More

View Article and Full-Text PDF
October 2021

Drug-coated Balloons for Small Coronary Disease-A Literature Review.

Curr Cardiol Rep 2021 Oct 14;23(11):173. Epub 2021 Oct 14.

Department of Cardiology, University Hospital Basel, University of Basel, Petersgraben 4, CH-4031, Basel, Switzerland.

Purpose Of Review: In the interventional treatment of coronary artery disease, new-generation drug-eluting stents (DES) currently are the standard treatment. In addition, drug-coated balloons (DCB) are a well-established option for the treatment of in-stent restenosis in both bare-metal stents (BMS) and DES, where DCBs deliver an antiproliferative drug without the necessity of re-implanting a stent. Since the field of use for DCB has increasingly been extended to other indications such as de novo lesions in small vessel disease (SVD), a review of literature may be useful. Read More

View Article and Full-Text PDF
October 2021

Effect of remote ischaemic conditioning on infarct size and remodelling in ST-segment elevation myocardial infarction patients: the CONDI-2/ERIC-PPCI CMR substudy.

Basic Res Cardiol 2021 Oct 14;116(1):59. Epub 2021 Oct 14.

The Hatter Cardiovascular Institute, University College London, London, WC1E 6HX, UK.

The effect of limb remote ischaemic conditioning (RIC) on myocardial infarct (MI) size and left ventricular ejection fraction (LVEF) was investigated in a pre-planned cardiovascular magnetic resonance (CMR) substudy of the CONDI-2/ERIC-PPCI trial. This single-blind multi-centre trial (7 sites in UK and Denmark) included 169 ST-segment elevation myocardial infarction (STEMI) patients who were already randomised to either control (n = 89) or limb RIC (n = 80) (4 × 5 min cycles of arm cuff inflations/deflations) prior to primary percutaneous coronary intervention. CMR was performed acutely and at 6 months. Read More

View Article and Full-Text PDF
October 2021

Vessel fractional flow reserve (vFFR) for the assessment of stenosis severity: the FAST II study.

EuroIntervention 2021 Oct 14. Epub 2021 Oct 14.

Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands.

Background: Fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) is superior to angiography-guided PCI. The clinical uptake of FFR has been limited, however, by the need to advance a wire in the coronary artery, the additional time required and the need for hyperaemic agents which can cause patient discomfort. FFR derived from routine coronary angiography eliminates these issues. Read More

View Article and Full-Text PDF
October 2021

A Comparison Between Two Definitions of Contrast-Associated Acute Kidney Injury for Long-Term Mortality in Elderly and Non-elderly Patients After Elective Percutaneous Coronary Intervention.

Front Cardiovasc Med 2021 27;8:720857. Epub 2021 Sep 27.

Department of Cardiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, China.

Contrast-associated acute kidney injury (CA-AKI) is responsible for a substantial proportion of the observed mortality that occurs after percutaneous coronary intervention (PCI), particularly in elderly patients. However, there has been significant and debate over whether the optimal definition of CA-AKI persists over prolonged periods due to variations in the prevalence and effects on prognosis. In this study, we aimed to identify whether different definitions of CA-AKI exert differential impacts on long-term mortality when compared between elderly and non-elderly patients receiving elective PCI. Read More

View Article and Full-Text PDF
September 2021

[Interim follow-up of fetal cardiac intervention in five fetuses with pulmonary atresia with intact ventricular septum].

Zhonghua Er Ke Za Zhi 2021 Sep;59(9):782-786

Department of Obstetrics, Women and Children's Hospital, Qingdao University, Qingdao 266034, China.

To summarize the interim outcome and right heart development of pulmonary atresia with intact ventricular septum (PA-IVS) in children after fetal cardiac intervention (FCI). The clinical data of 5 live births underwent FCI from October 2018 to April 2019 in Women and Children's Hospital, Qingdao University were analyzed retrospectively. The development of right ventricle (RV) and tricuspid valve (TV) in uterus after FCI, at birth, the age of 6 months, 1 year and 2 years, and the final outcome were assessed. Read More

View Article and Full-Text PDF
September 2021

The Effects of Glucose Lowering Agents on the Secondary Prevention of Coronary Artery Disease in Patients with Type 2 Diabetes.

Endocrinol Metab (Seoul) 2021 Oct 14. Epub 2021 Oct 14.

Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

Background: Patients with diabetes have a higher risk of requiring repeated percutaneous coronary intervention (PCI) than non-diabetic patients. We aimed to evaluate and compare the effects of anti-diabetic drugs on the secondary prevention of myocardial infarction among type 2 diabetes mellitus patients.

Methods: We analyzed the general health check-up dataset and claims data of the Korean National Health Insurance Service of 199,714 participants (age ≥30 years) who underwent PCIs between 2010 and 2013. Read More

View Article and Full-Text PDF
October 2021

Long-term effects of the mean hemoglobin A1c levels after percutaneous coronary intervention in patients with diabetes.

Korean J Intern Med 2021 Oct 14. Epub 2021 Oct 14.

Yeungnam University College of Medicine, Daegu, Korea.

Background/aims: The clinical benefit of strict blood glucose-lowering therapy for patients with coronary artery disease (CAD) is still debated. We aimed to evaluate the long-term outcomes of patients with diabetes who underwent percutaneous coronary intervention (PCI), according to the mean hemoglobin A1c (HbA1c) level after PCI.

Methods: We evaluated 675 diabetes patients with CAD treated with PCI. Read More

View Article and Full-Text PDF
October 2021

Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction.

PLoS One 2021 13;16(10):e0258525. Epub 2021 Oct 13.

Korea Institute of Toxicology, Daejeon, Republic of Korea.

Background: A substantial number of patients presenting with non-ST-elevation myocardial infarction (NSTEMI) and multivessel disease (MVD) have severe left ventricular systolic dysfunction (LVSD) (left ventricular ejection fraction (LVEF) less than 35%). But data are lacking regarding optimal percutaneous coronary intervention (PCI) strategy for these patients. The aim of this study was to compare the long-term outcomes of IRA (infarct-related artery)-only and multivessel PCI in patients with NSTEMI and MVD complicated by severe LVSD. Read More

View Article and Full-Text PDF
October 2021

Physician-pharmacist collaborative management in patients after percutaneous coronary intervention: a retrospective propensity score matching cohort study.

Int J Clin Pharm 2021 Sep 7. Epub 2021 Sep 7.

Department of Pharmacy, Xuanwu Hospital Capital Medical University, National Clinical Research Center for Geriatric Disease, Beijing, China.

Aim: Evaluate the effect of the Physician-Pharmacist Collaborative Management (PPCM) practice model in patients after percutaneous coronary intervention (PCI).

Method: A retrospective cohort study was conducted in post-PCI patients. The study enrolled patients who underwent PCI at our hospital from May 1, 2018, to January 31, 2020. Read More

View Article and Full-Text PDF
September 2021

Comparative Safety and Effectiveness of Loading Doses of P2Y12 Inhibitors in Patients Undergoing Elective PCI: a Network Meta-analysis.

Cardiovasc Drugs Ther 2021 Oct 13. Epub 2021 Oct 13.

Lehigh Valley Heart Institute, Lehigh Valley Health Network, Allentown, PA, USA.

Purpose: Effective platelet inhibition prior to elective percutaneous coronary intervention (PCI) reduces the risk of ischemic complications. Newer P2Y12 inhibitors are preferred agents over clopidogrel for patients presenting with the acute coronary syndrome. However, the comparative efficacy and safety of them over clopidogrel in elective PCI is unclear. Read More

View Article and Full-Text PDF
October 2021

The role of kidney function on patient survival after percutaneous coronary intervention for acute coronary syndrome in left main coronary artery disease.

Clin Nephrol 2021 Suppl;96(1):1-5

Background: The prevalence of chronic kidney disease (CKD) is increasing on a global scale. Patients with CKD have a reduced quality of life and are more likely to develop significant cardiovascular disease, most commonly coronary artery disease (CAD). Left main coronary artery disease (LMCAD) is one of the most severe forms of CAD, where revascularization is needed. Read More

View Article and Full-Text PDF
October 2021

Sex-related differences and rotational atherectomy - analysis of 5 177 percutaneous coronary interventions based on a large national registry from between 2014 and 2020.

Kardiol Pol 2021 Oct 13. Epub 2021 Oct 13.

Department of Cardiology and Cardiovascular Interventions, University Hospital, Kraków, Poland.

Background: Patients undergoing percutaneous coronary interventions (PCI) with rotational atherectomy (RA) have massively calcified coronary arteries and differ according to sex.

Aims: To assess trends in sex-related percentage shares in following years, to compare demographic characteristics between men and women, and to identify factors associated with the risk of periprocedural complications and death.

Methods: Based on the Polish National Registry of Percutaneous Coronary Interventions (ORPKI), we analyzed 751 113 patients treated with PCI between 2014 and 2020. Read More

View Article and Full-Text PDF
October 2021

Predictors and trends of contrast use and radiation exposure in a large cohort of patients treated with percutaneous coronary interventions: Chronic total occlusion analysis based on a national registry.

Cardiol J 2021 Oct 13. Epub 2021 Oct 13.

Department of Cardiology and Cardiovascular Interventions, University Hospital, Krakow, Poland.

Background: The aim herein, was to assess predictors and current trends of radiation exposure and total contrast amount use in patients treated with percutaneous coronary intervention within chronic total occlusion (CTO PCI) and non-CTO PCI.

Methods: Based on a nationwide registry (ORPKI), 535,857 patients treated with PCI between 2014 and 2018 were analysed. The study included 12,572 (2. Read More

View Article and Full-Text PDF
October 2021

Side-branch expansion capacity of contemporary DES platforms.

Eur J Med Res 2021 Oct 12;26(1):121. Epub 2021 Oct 12.

Institute for Implant Technology and Biomaterials-IIB E.V, Associated Institute of the University of Rostock, Warnemuende, Rostock, Germany.

Background: Percutaneous coronary interventions (PCI) of bifurcation stenoses are both complex and challenging. Stenting strategies share that the stents' side cells must be carefully explored and appropriately prepared using balloons or stents. So far, stent manufacturers have not provided any information regarding side-branch expansion capacity of their stent platforms. Read More

View Article and Full-Text PDF
October 2021

Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart Association.

Circulation 2021 Oct 13:CIR0000000000001025. Epub 2021 Oct 13.

The introduction of Mission: Lifeline significantly increased timely access to percutaneous coronary intervention for patients with ST-segment-elevation myocardial infarction (STEMI). In the years since, morbidity and mortality rates have declined, and research has led to significant developments that have broadened our concept of the STEMI system of care. However, significant barriers and opportunities remain. Read More

View Article and Full-Text PDF
October 2021

Caval Valve Implantation (CAVI): An Emerging Therapy for Treating Severe Tricuspid Regurgitation.

J Clin Med 2021 Oct 7;10(19). Epub 2021 Oct 7.

Department of Cardiology, Cleveland Clinic, Cleveland, OH 44195, USA.

Severe tricuspid regurgitation remains a challenging heart-valve disease to effectively treat with high morbidity and mortality at mid-term. Currently guideline-directed medical treatment is limited to escalating dose of diuretics, and the rationale and timing of open-heart surgery remains controversial. Emerging percutaneous therapies for severe tricuspid regurgitation continue to show promising results in early feasibility studies. Read More

View Article and Full-Text PDF
October 2021

Risk Stratification of Patients with Acute Coronary Syndrome.

J Clin Med 2021 Oct 1;10(19). Epub 2021 Oct 1.

Department of Cardiology, Third Faculty of Medicine, Charles University, University Hospital Královské Vinohrady, 100 34 Prague, Czech Republic.

Defining the risk factors affecting the prognosis of patients with acute coronary syndrome (ACS) has been a challenge. Many individual biomarkers and risk scores that predict outcomes during different periods following ACS have been proposed. This review evaluates known outcome predictors supported by clinical data in light of the development of new treatment strategies for ACS patients during the last three decades. Read More

View Article and Full-Text PDF
October 2021

The Common Combination of Aortic Stenosis with Mitral Regurgitation: Diagnostic Insight and Therapeutic Implications in the Modern Era of Advanced Echocardiography and Percutaneous Intervention.

J Clin Med 2021 Sep 24;10(19). Epub 2021 Sep 24.

Section of Cardiology, University of Verona, 37129 Verona, Italy.

The combination of aortic stenosis (AS) and mitral regurgitation (MR) is common in patients with degenerative valvular disease. It is characterized by having complex pathophysiology, leading to potential diagnostic pitfalls. Evidence is scarce in the literature to direct the diagnostic framework and treatment of patients with this particular combination of multiple valvular diseases. Read More

View Article and Full-Text PDF
September 2021

Percutaneous Coronary Intervention (PCI) Reprograms Circulating Extracellular Vesicles from ACS Patients Impairing Their Cardio-Protective Properties.

Int J Mol Sci 2021 Sep 24;22(19). Epub 2021 Sep 24.

Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Extracellular vesicles (EVs) are promising therapeutic tools in the treatment of cardiovascular disorders. We have recently shown that EVs from patients with Acute Coronary Syndrome (ACS) undergoing sham pre-conditioning, before percutaneous coronary intervention (PCI) were cardio-protective, while EVs from patients experiencing remote ischemic pre-conditioning (RIPC) failed to induce protection against ischemia/reperfusion Injury (IRI). No data on EVs from ACS patients recovered after PCI are currently available. Read More

View Article and Full-Text PDF
September 2021

Impact of percutaneous ventricular septal defect closure on left ventricular remodeling and function.

Egypt Heart J 2021 Oct 12;73(1):86. Epub 2021 Oct 12.

Cardiology Department, Faculty of Medicine, Helwan University, Cairo, Egypt.

Background: Ventricular septal defect (VSD) is the most common congenital heart disease. In patients with large VSD, left side chambers are subjected to volume overload with subsequent chambers dilatation and eccentric left ventricular hypertrophy. Percutaneous closure of VSD has been shown to be an effective method with equal safety and efficacy when compared to surgery. Read More

View Article and Full-Text PDF
October 2021

Efficacy and safety of bivalirudin without post-procedure infusion in patients with coronary heart disease during elective percutaneous coronary intervention: a real-world study.

Chin Med J (Engl) 2021 Oct 11. Epub 2021 Oct 11.

Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China Department of Pharmacy, The People's Hospital of Langfang, Langfang, Hebei 065000, China Department of Cardiology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116023, China.

View Article and Full-Text PDF
October 2021

Impact of persistent subclinical hypothyroidism on clinical outcomes in non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.

Clin Endocrinol (Oxf) 2021 Oct 12. Epub 2021 Oct 12.

The Eighth Department of Cardiology, Tianjin Chest Hospital, Tianjin, China.

Background: Data on the association of subclinical hypothyroidism (SCH) with the severity of coronary artery disease and major adverse cardiovascular and cerebral events (MACCE) in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) after percutaneous coronary intervention (PCI) are limited and conflicting.

Objective: We established the baseline rate of SCH and followed the trajectory of thyroid-stimulating hormone (TSH) values during and after hospitalisation for PCI for up to six months and determined whether persistent SCH was associated with the severity of coronary artery disease and MACCE in patients with NSTE-ACS after PCI.

Design: Population-based prospective cohort study. Read More

View Article and Full-Text PDF
October 2021

Association between perceived health and adherence to treatment after percutaneous coronary intervention: A long-term follow-up study.

J Adv Nurs 2021 Oct 12. Epub 2021 Oct 12.

Research Unit of Nursing Science and Health Management, Faculty of Medicine, University of Oulu, Oulu, Finland.

Aims: To identify associations between perceived health and treatment adherence six years after percutaneous coronary intervention.

Design: A non-experimental descriptive long-term follow-up study.

Methods: Baseline data (n = 416) were collected in 2013, with follow-up data collected in 2019 (n = 154), using the EuroQoL scale, EuroQoL visual analogue scale, and Adherence of Patients with Chronic Disease Instrument. Read More

View Article and Full-Text PDF
October 2021

Association between phosphate and long-term outcome in CAD patients underwent coronary intervention.

Sci Rep 2021 Oct 11;11(1):20080. Epub 2021 Oct 11.

Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

Phosphate has been linked to higher cardiovascular (CV) risk. However, whether phosphate is associated with poor outcomes for patients with coronary artery disease (CAD) after percutaneous coronary interventions (PCIs) remained undetermined. 2,894 CAD patients (2,220 male, aged 71. Read More

View Article and Full-Text PDF
October 2021

A nationwide survey on participation in cardiac rehabilitation among patients with coronary heart disease using health claims data in Japan.

Sci Rep 2021 Oct 11;11(1):20096. Epub 2021 Oct 11.

Division of Medical Information Technology and Administration Planning, Kyoto University Hospital, 54 Shogoin-kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.

Poor implementation and variable quality of cardiac rehabilitation (CR) for coronary heart disease (CHD) have been a global concern. This nationwide study aimed to clarify the implementation of and participation in CR among CHD patients and associated factors in Japan. We conducted a retrospective cohort study using data extracted from the National Database of Health Insurance Claims and Specific Health Checkups of Japan. Read More

View Article and Full-Text PDF
October 2021

Impaired autonomic function after incomplete revascularisation.

Open Heart 2021 Oct;8(2)

Department of Cardiology, St James Hospital, Dublin, Ireland.

Introduction: Incomplete cardiac revascularisation (ICR) assessed by residual SYNTAX score (rSs) is associated with increased 5-year mortality. Furthermore, in the general population, our group has demonstrated that impaired autonomic function determined by heart rate recovery time between 10 and 20 s (HRR) following an active stand is associated with increased all-cause mortality.

Purpose: We hypothesised that ICR would be associated with impaired autonomic function determined by HRR. Read More

View Article and Full-Text PDF
October 2021

[Challenges of coronary catheterization after TAVR].

Ann Cardiol Angeiol (Paris) 2021 Oct 8. Epub 2021 Oct 8.

Service de Cardiologie, Centre Hospitalier Haguenau, 67 Avenue du Professeur René Leriche, 67500, Haguenau.

Purpose: Coronary catheterization after transcatheter aortic valve implantation (TAVR) may be challenging. The main objective of the study is to assess the feasibility of coronary catheterization and angioplasty according to each type of valve.

Patients And Method: We retrospectively studied coronary angiography or percutaneous angioplasty procedures after TAVR in two different centers. Read More

View Article and Full-Text PDF
October 2021

[Optimisation du traitement médical en réadaptation cardiaque (METRO study) : étude multicentrique française].

Ann Cardiol Angeiol (Paris) 2021 Oct 8. Epub 2021 Oct 8.

Sports Medicine Department, CHU Rennes, 35033Rennes, France.

Background: Cardiac rehabilitation (CR) is the right place to optimize the medical treatment in coronary artery disease (CAD) patients.

Aims: To report the medical management in CAD patients during CR and evaluate the consequences.

Methods: CAD patients who attended a CR program within less than three months of an acute coronary syndrome (ACS), a percutaneous coronary intervention (PCI), or a coronary artery bypass graft (CABG) were included in a prospective multicenter study. Read More

View Article and Full-Text PDF
October 2021

Regional end-systolic circumferential strain demonstrates compensatory segmental contractile function in patients with ST-segment elevation myocardial infarction.

J Biomech 2021 Oct 5;129:110794. Epub 2021 Oct 5.

Department of Mechanical Engineering, College of Engineering, University of Kentucky, Lexington, KY, United States; Department of Surgery, College of Medicine, University of Kentucky, Lexington, KY, United States. Electronic address:

Myocardial strain has shown tremendous promise as a potential diagnostic tool for characterizing ventricular function. With regards to myocardial infarction, global circumferential strain (CS) can be used to assess overall function, while regional CS can identify local alterations in contractility. Currently, there is a lack of data related to regional strain in patients with ST-segment elevation myocardial infarction (STEMI). Read More

View Article and Full-Text PDF
October 2021